Investors in Healthtec

CG Health Ventures specializes in investing in innovative startups, particularly within Health IT, Digital Health, and Genomics sectors. They focus on early-stage projects, often at the concept stage, seeking entrepreneurs with ambitious visions and a resilient drive to achieve their goals. Emphasizing a strong values alignment, CG Health Ventures aims to forge effective and enjoyable working relationships with their portfolio companies. They actively engage with startups, leveraging their passion, experience, and network to provide hands-on support throughout the entrepreneurial journey. While they have a global outlook, their primary operational focus and network are centered in Europe and the US.

VAS Ventures, led by serial entrepreneur Martin Varsavsky, focuses on early stage investments in companies with ambitious founders driving innovation. Known for his successful ventures and investments in transformative startups, Martin Varsavsky personally mentors portfolio companies, leveraging his entrepreneurial expertise and network to foster their growth and success. VAS Ventures is an early stage investment fund looking for companies in the mobility, mobile and SaaS space.

Invivo Partners is a venture capital firm specializing in early-stage healthcare companies, led by Luis Pareras, Albert Ferrer, and Laura Rodríguez. With investments in 15 portfolio companies and 3 successful exits, their portfolio companies have collectively raised over 350M€ from global VCs. The team at Invivo Partners combines scientific, technical, and financial expertise to make impactful investments and drive growth in the health sector. With a strong focus on Technology Transfer and market trends, the firm aims to establish itself as a key player in Europe's biotech industry. Invivo Partners' investor base includes major institutional investors such as the European Investment Fund, Instituto de Crédito Oficial (ICO), Institut Català de Finances (ICF), Institut Valencià de Finances (IVF), Barcelona City Council, alongside a majority of private investors. Initial investments typically range from 2-4M€, with follow-on investments up to 10M€ per company after achieving specified milestones. The firm specializes in pre-seed and seed investments, particularly in companies at the preclinical stage, and also participates in Series A investments for companies approximately 1-2 years away from First-in-Human trials. Invivo Partners focuses primarily on European-based opportunities, with a special emphasis on Spanish biotechnology companies developing innovative drugs, particularly in Advanced Therapies and Synthetic Biology.

Clave is an investment management company. Their cornerstone is commitment. They advance innovative projects and industrial SMEs through strategic investments and active engagement in the company's value creation journey. Their hallmark is professionalism, boasting over 16 years of experience marked by more than 65 investments. They specialize in shaping strategy and management across diverse sectors including technology, renewable energy, agri-food, among others. They emphasize team integration, fostering collaborative partnerships with founders and management teams. This approach aims to bolster company growth and tackle emerging market demands effectively.

Clave is an investment management company. Their cornerstone is commitment. They advance innovative projects and industrial SMEs through strategic investments and active engagement in the company's value creation journey. Their hallmark is professionalism, boasting over 16 years of experience marked by more than 65 investments. They specialize in shaping strategy and management across diverse sectors including technology, renewable energy, agri-food, among others. They emphasize team integration, fostering collaborative partnerships with founders and management teams. This approach aims to bolster company growth and tackle emerging market demands effectively.

Aldea Ventures is a Barcelona-based pan-European venture capital platform specializing in investing in the next generation of technology leaders. Founded in 2020, they employ a pioneering hybrid strategy: supporting specialized emerging fund managers in early-stage investments while co-investing in growth-stage companies. Their diverse portfolio includes over 50 fund managers and companies like Automata, Kenbi, Podimo, Sorare, as well as funds such as Moonfire and Cocoa. Aldea Ventures aims to advance cutting-edge technologies across Europe, connecting VC talent with startup ecosystems and enhancing their understanding of the European tech landscape.